Bulatov ER - Search Results

1

Multicellular Cancer-Stroma Spheres (CSS) for In Vitro Assessment of CAR-T Cell-Associated Toxicity.

Rakhmatullina AR, Zolotykh MA, Filina YV, Valiullina AK, Zmievskaya EA, Gafurbaeva DU, Sagdeeva AR, Bulatov ER, Rizvanov AA, Miftakhova RR. Rakhmatullina AR, et al. Among authors: bulatov er. Cells. 2024 Nov 16;13(22):1892. doi: 10.3390/cells13221892. Cells. 2024. PMID: 39594640 Free PMC article.

2

Biophysical studies on interactions and assembly of full-size E3 ubiquitin ligase: suppressor of cytokine signaling 2 (SOCS2)-elongin BC-cullin 5-ring box protein 2 (RBX2).

Bulatov E, Martin EM, Chatterjee S, Knebel A, Shimamura S, Konijnenberg A, Johnson C, Zinn N, Grandi P, Sobott F, Ciulli A. Bulatov E, et al. J Biol Chem. 2015 Feb 13;290(7):4178-91. doi: 10.1074/jbc.M114.616664. Epub 2014 Dec 11. J Biol Chem. 2015. PMID: 25505247 Free PMC article.

3

Binding and purification of plasmid DNA using multi-layered carbon nanotubes.

Shakhmaeva II, Bulatov ER, Bondar OV, Saifullina DV, Culha M, Rizvanov AA, Abdullin TI. Shakhmaeva II, et al. Among authors: bulatov er. J Biotechnol. 2011 Mar 20;152(3):102-7. doi: 10.1016/j.jbiotec.2011.01.022. Epub 2011 Feb 3. J Biotechnol. 2011. PMID: 21295626

4

Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets.

Bulatov E, Zagidullin A, Valiullina A, Sayarova R, Rizvanov A. Bulatov E, et al. Front Pharmacol. 2018 May 8;9:450. doi: 10.3389/fphar.2018.00450. eCollection 2018. Front Pharmacol. 2018. PMID: 29867461 Free PMC article. Review.

5

Promising new therapeutic targets for regulation of inflammation and immunity: RING-type E3 ubiquitin ligases.

Bulatov E, Valiullina A, Sayarova R, Rizvanov A. Bulatov E, et al. Immunol Lett. 2018 Oct;202:44-51. doi: 10.1016/j.imlet.2018.08.001. Epub 2018 Aug 9. Immunol Lett. 2018. PMID: 30099009 Review.

6

The biological basis and clinical symptoms of CAR-T therapy-associated toxicites.

Titov A, Petukhov A, Staliarova A, Motorin D, Bulatov E, Shuvalov O, Soond SM, Piacentini M, Melino G, Zaritskey A, Barlev NA. Titov A, et al. Cell Death Dis. 2018 Sep 4;9(9):897. doi: 10.1038/s41419-018-0918-x. Cell Death Dis. 2018. PMID: 30181581 Free PMC article. Review.

7

Isatin-Schiff base-copper (II) complex induces cell death in p53-positive tumors.

Bulatov E, Sayarova R, Mingaleeva R, Miftakhova R, Gomzikova M, Ignatyev Y, Petukhov A, Davidovich P, Rizvanov A, Barlev NA. Bulatov E, et al. Cell Death Discov. 2018 Nov 13;4:103. doi: 10.1038/s41420-018-0120-z. eCollection 2018. Cell Death Discov. 2018. PMID: 30455989 Free PMC article.

8

Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment.

Titov A, Valiullina A, Zmievskaya E, Zaikova E, Petukhov A, Miftakhova R, Bulatov E, Rizvanov A. Titov A, et al. Cancers (Basel). 2020 Jan 3;12(1):125. doi: 10.3390/cancers12010125. Cancers (Basel). 2020. PMID: 31947775 Free PMC article. Review.

9

Novel Isatin-based activator of p53 transcriptional functions in tumor cells.

Mirgayazova R, Khadiullina R, Mingaleeva R, Chasov V, Gomzikova M, Garanina E, Rizvanov A, Bulatov E. Mirgayazova R, et al. Mol Biol Res Commun. 2019 Sep;8(3):119-128. doi: 10.22099/mbrc.2019.34179.1419. Mol Biol Res Commun. 2019. PMID: 31998813 Free PMC article.

10

Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?

Mirgayazova R, Khadiullina R, Chasov V, Mingaleeva R, Miftakhova R, Rizvanov A, Bulatov E. Mirgayazova R, et al. Genes (Basel). 2020 Jun 25;11(6):704. doi: 10.3390/genes11060704. Genes (Basel). 2020. PMID: 32630614 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters